Researchers have developed a new strategy for characterizing large populations of patients with autosomal dominant polycystic kidney disease (ADPKD). Rossetti and co-workers used their approach of next-generation DNA sequencing to characterize a cohort of 230 patients with ADPKD. They found that their process was able to detect definitely and likely pathogenic variants in 115 (63%) of 183 patients with typical ADPKD.